Graham Capital Management’s Pulmonx LUNG Stock Holding History

Graham Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34,241	Closed	-$88.7K	–	1477
2025 Q2	$88.7K	Buy	34,241 +17,618	+106%	+$69.5K	﹤0.01%	1217
2025 Q1	$112K	Sell	16,623 -1,448	-8%	-$10.3K	﹤0.01%	1199
2024 Q4	$123K	Buy	18,071 +7,641	+73%	+$50.3K	﹤0.01%	1139
2024 Q3	$86.5K	Sell	10,430 -22,278	-68%	-$161K	﹤0.01%	1017
2024 Q2	$207K	Buy	32,708 +13,714	+72%	+$105K	﹤0.01%	853
2024 Q1	$176K	Buy	+18,994	New	+$223K	﹤0.01%	917
2023 Q4	–	Sell	-10,101	Closed	-$104K	–	1182
2023 Q3	$104K	Sell	10,101 -1,384	-12%	-$16K	﹤0.01%	934
2023 Q2	$151K	Buy	+11,485	New	+$140K	﹤0.01%	855
2022 Q3	–	Sell	-19,038	Closed	-$280K	–	1199
2022 Q2	$280K	Buy	+19,038	New	+$392K	0.01%	852

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Graham Capital Management's LUNG Position: Q3 2025 in Review

Graham Capital Management sold out of Pulmonx (LUNG) in Q3 2025, closing a stake of 34,241 shares — an estimated $88.7K sold.

Graham Capital Management first reported a position in LUNG in Q2 2022 and held it in 9 quarters. The position peaked at $280K in Q2 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q3 2025.

Graham Capital Management reported no remaining Pulmonx position as of Q3 2025 after selling out during the quarter.
Graham Capital Management sold 34,241 Pulmonx shares in Q3 2025, an estimated $88.7K.
Graham Capital Management first reported a position in Pulmonx in Q2 2022 and held it in 9 quarters.
Graham Capital Management's Pulmonx position peaked at $280K in Q2 2022.
107 funds tracked by Wall St. Rank held Pulmonx as of Q3 2025.

Based on Graham Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.